This infographic provides a structured, high-yield overview aligned with clinical and academic frameworks, covering: Core pharmacology and mechanism of action Key pharmacological effects on glucose homeostasis and appetite regulation Evidence-based therapeutic indications (Type 2 Diabetes & Obesity) Safety profile including side effects, toxicity risks, and contraindications Pharmacokinetics: metabolism, half-life, and excretion pathways Drug-drug interaction considerations for clinical optimization Overview of globally recognized brands such as semaglutide, liraglutide, dulaglutide, and tirzepatide formulations From enhancing insulin secretion to delaying gastric emptying, GLP-1 analogs are redefining patient-centric outcomes with a strong efficacy-safety balance
Cognitive impairment In rats, supplementation with a high, but not a low, dose of taurine, (P21-30), ameliorated the PRS-induced cognitive deficits in the MWM at P31 [117]
Most of these alternatives are available in the UK through private clinics
Glutathione is part of that equation